|drug3122||Standard Of Care (SOC) Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.
Description: COVID-19 related complications that require the participant to be hospitalized or have an emergency room visitMeasure: Number of participants hospitalized and/or requiring repeat emergency room visits Time: 21 days
Description: If hospitalized, number of participants admitted to the ICU, and number of days in the ICUMeasure: Number of participants admitted to the Intensive care unit (ICU) Time: 30 days
Description: If placed on ventilator, number of days on a ventilatorMeasure: Number of participants on a ventilator Time: 30 days
Description: Total number of deaths in the cohort.Measure: All-cause mortality Time: Up to 30 days
Description: Time at which the patient is completely symptom free.Measure: Time to resolution of COVID-19 symptoms Time: Evaluated at day 2, 6, day 14, and day 21
Description: Scored by the participant for feverishness, sore throat, cough, shortness of breath, myalgias. (0 =none; 1 = mild; 2 = moderate; 3 = severe)Measure: Severity of symptoms Time: Evaluated at day 2, 6, day 14, and day 21
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports